A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
Introduction: Muscle-specific kinase (MuSK)- myasthenia gravis (MG) is caused by pathogenic autoantibodies against MuSK that correlate with disease severity and are predominantly of the IgG4 subclass. The first-line treatment for MuSK-MG is general immunosuppression with corticosteroids, but the eff...
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Frontiers Media
2024
|